Biochemical recurrence after definitive prostate cancer therapy. Part II: treatment strategies for biochemical recurrence of prostate cancer.
about
Development of a nomogram model predicting current bone scan positivity in patients treated with androgen-deprivation therapy for prostate cancer.The need for a personalized approach for prostate cancer management.Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.Exisulind in the treatment of prostate cancer.The impact of adjuvant therapy in patients with biochemical recurrence on prostate cancer progression and mortality five years after radical prostatectomy.
P2860
Biochemical recurrence after definitive prostate cancer therapy. Part II: treatment strategies for biochemical recurrence of prostate cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Biochemical recurrence after d ...... recurrence of prostate cancer.
@ast
Biochemical recurrence after d ...... recurrence of prostate cancer.
@en
type
label
Biochemical recurrence after d ...... recurrence of prostate cancer.
@ast
Biochemical recurrence after d ...... recurrence of prostate cancer.
@en
prefLabel
Biochemical recurrence after d ...... recurrence of prostate cancer.
@ast
Biochemical recurrence after d ...... recurrence of prostate cancer.
@en
P1476
Biochemical recurrence after d ...... recurrence of prostate cancer.
@en
P2093
John F Ward
Judd W Moul
P304
P356
10.1097/01.MOU.0000165553.17534.E3
P577
2005-05-01T00:00:00Z